Syncom Formulations (India) Ltd. (SYNCOMF): Syncom Formulations Share Price rises 8.43% to Rs 17.50
- August 24, 2026
- Posted by: Harsh Piplani
- Category: News
Syncom Formulations Share Price rose to Rs 17.50, up 8.43% today, with market capitalisation at Rs 1,517.16 Cr. The move is confirmed by the price data, while the supplied record does not establish a company-specific catalyst.
Syncom Formulations Share Price is in focus after the stock rose 8.43% today to Rs 17.50 from Rs 16.14. The company’s market capitalisation stands at Rs 1,517.16 Cr, placing the move in a clear market-cap context for investors tracking Syncom Formulations Share Price Today on Univest.
The day’s move was supported by a higher close than the previous close, with the stock opening at Rs 16.28, touching Rs 17.60, and finishing near the upper end of the session range. The supplied data confirms a same-day share price rise, but it does not establish a company-specific trigger. For readers following Syncom Formulations Stock News and Syncom Formulations Share Price News, the key question is not only what changed in the quote, but also how that move fits with valuation, sector context and company fundamentals.
On Univest, Syncom Formulations Share Price can be tracked alongside broader Syncom Formulations Stock Analysis, Syncom Formulations Latest News and Syncom Formulations Share Price Update views as the session data evolves.
Syncom Formulations Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 17.5 |
| Previous Close | Rs 16.14 |
| Today's Move | Rs 1.36 (+8.43%) |
| Open | Rs 16.28 |
| High | Rs 17.6 |
| Low | Rs 16.28 |
| Turnover | Rs 1.19 crore |
| Market Capitalisation | Rs 1,517.16 crore |
| Market Cap Category | Small Cap |
Syncom Formulations (India) Ltd. (SYNCOMF) rose to Rs 17.5 from the previous close of Rs 16.14, a move of Rs 1.36 or 8.43%. The stock opened at Rs 16.28, reached a high of Rs 17.6, recorded a low of Rs 16.28.
Syncom Formulations Share Price Today moved from Rs 16.14 to Rs 17.50, a gain of Rs 1.36 or 8.43%. The stock opened at Rs 16.28, marked a day low of Rs 16.28 and a day high of Rs 17.60, while turnover stood at Rs 1.19 Cr. This confirms a strong one-day price rise without assigning a cause. For investors scanning Stocks in News and Top Gainers Today, the factual takeaway is the size of the move, the intraday range and the closing level relative to the previous close. The same figures also make Syncom Formulations Share Price a notable entry in today’s Indian Stock Market and Share Market Today updates.
Syncom Formulations (India) Ltd. (SYNCOMF) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,517.16 crore |
| P/E Ratio | 17.74x |
| P/B Ratio | 3.45x |
| ROE | 15.69% |
| ROCE | 18.77% |
| EPS | Rs 0.91 |
| Book Value Per Share | Rs 4.68 |
| Dividend Yield | 0% |
Syncom Formulations (India) Ltd. (SYNCOMF) fundamental metrics show P/E 17.74x, P/B 3.45x, ROE 15.69%, ROCE 18.77%. These figures provide context only and are not a buy or sell signal.
Syncom Formulations (India) Ltd. has a market capitalisation of Rs 1517.16 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 17.74x, P/B at 3.45x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 15.69% and ROCE of 18.77%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 0.91, book value per share of Rs 4.68, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.9x, median ROE of 11.79%, median ROCE of 13.66%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 17.74x |
| Benchmark Median P/E | 30.9x |
| Benchmark Average P/E | 46.33x |
| Benchmark P/E Range | 2.94x to 689.27x |
| Company P/B Ratio | 3.45x |
| Benchmark Median P/B | 2.59x |
| Company ROE | 15.69% |
| Benchmark Median ROE | 11.79% |
| Company ROCE | 18.77% |
| Benchmark Median ROCE | 13.66% |
| Company Market Capitalisation | Rs 1,517.16 crore |
| Benchmark Median Market Cap | Rs 519.82 crore |
Syncom Formulations (India) Ltd. (SYNCOMF) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Syncom Formulations (India) Ltd. (SYNCOMF) has a P/E ratio of 17.74x, which is below the benchmark median of 30.9x, a difference of -42.59%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Syncom Formulations (India) Ltd. (SYNCOMF) has a ROE of 15.69%, which is above the benchmark median of 11.79%, a difference of +33.08%. Syncom Formulations (India) Ltd. (SYNCOMF) has a ROCE of 18.77%, which is above the benchmark median of 13.66%, a difference of +37.41%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,56,089.58 | 37.71 | 5.27 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,26,975.64 | 77.6 | 12.85 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,85,638.53 | 85.12 | 20.68 | 26.76 | 19.27 |
| Cipla Ltd. | CIPLA | 1,15,216.02 | 34.18 | 3.28 | 11.83 | 16 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,11,720.43 | 24.76 | 4.14 | 19.69 | 21.39 |
Syncom Formulations (India) Ltd. (SYNCOMF) has a P/E ratio of 17.74x compared with the displayed peer median of 37.71x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 15.69% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 18.77% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Syncom Formulations (India) Ltd. (SYNCOMF) has a market capitalisation of Rs 1,517.16 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Syncom Formulations
- Syncom Formulations Share Price rose 8.43% today to Rs 17.50 from Rs 16.14.
- The intraday range was Rs 16.28 to Rs 17.60, with turnover of Rs 1.19 Cr.
- Market capitalisation is Rs 1,517.16 Cr, which frames the move in size terms.
- P/E of 17.74 and P/B of 3.45 give a direct valuation reference.
- ROE of 15.69% and ROCE of 18.77% provide profitability context versus peers.
About Syncom Formulations (India) Ltd.
Syncom Formulations (India) Ltd. operates in Healthcare and the Pharmaceuticals & Drugs industry. The supplied data does not break out revenue segments or product lines, so the business description is best kept to the verified company and industry profile. For investors tracking Syncom Formulations Share Price, the relevant point is that the company belongs to a sector where valuation, profitability and peer comparison often influence how stock moves are interpreted.
On Univest, Syncom Formulations Stock News is therefore most useful when read together with company valuation, market capitalisation and the broader industry benchmark. That helps place Syncom Formulations Share Price Today into a factual research framework rather than a one-line market update.
Track Syncom Formulations Share Price on Univest
Use Syncom Formulations (India) Ltd. (SYNCOMF) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Readers can track Syncom Formulations Share Price on Univest for live share price updates, fundamental ratios, shareholding pattern, 52-week levels and market insights. The platform also helps compare Syncom Formulations Stock Analysis with peers, sector numbers and company financial metrics in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Syncom Formulations Share Price rise today?
Ans. The data confirms an 8.43% rise to Rs 17.50, but it does not establish a company-specific catalyst. The move is visible in the session numbers, not in any supplied event reason.
What is Syncom Formulations Share Price Today?
Ans. Syncom Formulations Share Price Today is Rs 17.50, compared with a previous close of Rs 16.14. The stock gained Rs 1.36 in the session and ended near the top of its trading range.
What is the market capitalisation of Syncom Formulations?
Ans. Syncom Formulations has a market capitalisation of Rs 1,517.16 Cr. That figure places the company above the industry median market cap in the supplied benchmark set, though below the industry average.
How is Syncom Formulations valued on earnings?
Ans. Syncom Formulations has a P/E ratio of 17.74 and a P/B ratio of 3.45. In the supplied industry benchmark, its P/E is below the median and average, while its P/B is above the median.
What do Syncom Formulations ROE and ROCE show?
Ans. ROE is 15.69% and ROCE is 18.77%. Both are above the supplied industry medians and averages, which gives investors a clear profitability reference when reviewing Syncom Formulations Share Price. ROE stands at 15.69%.
How does Syncom Formulations compare with peers?
Ans. In the supplied peer set, Syncom Formulations has a much smaller market capitalisation than listed peers and a lower P/E than each one. Its ROE and ROCE remain competitive versus some peers.
What are the key price levels from today’s session?
Ans. Syncom Formulations opened at Rs 16.28, touched a low of Rs 16.28 and a high of Rs 17.60, before closing at Rs 17.50. These are the key factual levels from today’s move.
